v3.26.1
Accrued Liabilities
3 Months Ended
Mar. 31, 2026
Accrued Liabilities, Current [Abstract]  
Accrued Liabilities Accrued Liabilities
Accrued liabilities as of March 31, 2026 and December 31, 2025 consisted of the following (in thousands):
 March 31,
2026
December 31,
2025
Rebates, returns and other revenue related reserves$120,750 $90,504 
Clinical study, manufacturing and drug supply
36,862 26,907 
Compensation and benefits34,330 69,211 
Selling, general and administrative46,826 40,026 
Other36,993 33,744 
Total accrued liabilities$275,761 $260,392